Hexahydrocannabinol and Hexahydrocannabiphorol Poisonings: Data From the Czech Toxicology Information Centre and Effects of Legislative Changes
Abstract Hexahydrocannabinol, a hydrogenated derivative of cannabinol, first came to the Czech Toxicological Information Centre (TIC) following reports of poisonings in May 2022. We conducted a retrospective observational study examining self‐reported cases of hexahydrocannabinol and hexahydrocannabiphorol exposure reported to the TIC from May 17, 2022, to April 30, 2024. Of 236 cases reported, 40 (17%) were excluded. The median age of patients was 18 years (range 1.5–73), with a male predominance of 55.8%. Notably, 39 children under 15 years constituted
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
